Abstract
The polyunsaturated fatty acids (PUFAs), linoleic acid (LA), alpha linolenic acid (ALA), gamma linolenic acid (GLA), arachidonic acid (AA), docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), showed inhibition of growth of both normal and abnormal (Molt-4) human lymphocytes, and inhibition was concentration-dependent. Interestingly, the production of the lymphokine Interleukin-2 (IL-2) was elevated in Molt-4 cells, but it was reduced in the normal human lymphocytes. Addition of GLA or IL-2 or a combination of both showed enhancement of SO −2 and of lipid peroxidation levels, which were significantly higher in Molt-4 cells than in the normal lymphocytes. Reduction of protein concentration was also observed in both types of cells during this treatment. The data showed that the antiproliferative effects of GLA and IL-2 may partly be exerted through the elevated production of superoxide free radicals and peroxidatin products. This is a novel finding and therefore, further exploitation of combinations of PUFAs and IL-2 may be a possible way of combating cancer cell growth.
Similar content being viewed by others
Literatur
Morgan, D. A., Ruscetti, F. W., and Gallo, R., Science193 (1976) 1007.
Balkwill, F. R., in: Cytokines in Cancer Therapy, p. 88, Ed. F. R. Balkwill. Oxford University Press, England 1989.
West, W. H., Eur. J. Cancer clin. Oncol.25(3) (1989) 11.
rosenberg, S. A., Cancer Res.51 (1991) 5074.
Rosenberg, S. A., Lotze, M. T., Muul, L. M., Chang, A. E., Avis, E. P., Leitman, S., Linehan, W. M., Robertson, C. N., Lee, R. E., and Rubin, J. T., N. Engl. J. Med.316 (1987) 889.
Dunbar, L.M., and Bailey, J. M., J. biol. Chem.250 (1975) 1152.
Das, U. N., Med. Sci. Res.15 (1987) 1485.
Cornwell, G., and Morisaki, N., in: Prostaglandins, Lipid peroxides and Co-oxidation Reactions (5), p. 95. Ed. W. A. Pryor. Academic Press, New York 1984.
Smith, D. L., Willis, A. L., and Mahmud, I., Prostaglandins Leukotrienes Med.16 (1984) 1.
Das, U. N., Begin, M. E., Ells, G., Huang, Y. S., and Horrobin, D. F., Biochem. biophys. Res. Commun.145(1) (1986) 15.
Perkin, D. M., and Duncan, J. R., Prostaglandins Leukotrienes Essential Fatty Acids43 (1991) 43.
Santoli, D., and Zurier, R. B., J. Immun.143 (1989) 1303.
Mcphail, L. C., and Synderman, L., Contemp. Topics Immunobiol.14 (1984) 247.
Sangeetha, P., Das, U. N., and Koratkar, R., Prostaglandins Leukotrienes Essential Fatty Acids39 (1990) 27.
Sravan Kumar, G., Das, U. N., Vijay Kumar, K., Madhavi, N., Das, N. P., and Tan, B. K. H., Nutr. Res.12 (1992) 815.
Galeotti, T., Bautoli, G. M., and Bartoli, E. in: Biological and Clinical Aspects of Superoxide and Superoxide Dismutase, p. 106. Eds W. H. Bannister and J. V. Bannister (Proc. Fed. Eur. biochem. Societies Symposium.62 (1982)) 1982.
Boyum, A., J. clin. Invest.21(97) (1968) 245.
Ambika Devi, M., and Das, N. P., Cancer Letts69 (1993) 191.
Das, N. P., and Allen, C. M., Biochem. biophys. Res. Commun.181 (1991) 729.
Ratty, A. K., and Das, N. P., IRCS14 (1986) 815.
Ramanathan, L., and Das, N. P., J Agric. Fd. Chem.40 (1992) 17.
Snedecor, G. W., and Cochran, W.G., (eds) in: Statistical Methods, p. 172. Iowa State University Press, Ames, IA 1971.
Tsuijimoto, M., Yokota, S., Vilcek, J., and Weissman, G., Biochem. biophys. Res. Commun.137 (1986) 1094.
Berton, G., Zeni, L., Cassatella, M. A., and Ross, F., Biochem. biophys. Res. Commun.138 (1987) 1276.
Schlager, L. D., and Meltzer, M. S., Cell Immun.80 (1983) 10.
Das, U. N., Prostaglandins Leukotrienes and Essential Fatty Acids44 (1991) 201.
Zurier, R. B., Prostaglandins Leukotrienes and Essential Fatty Acids48 (1993) 57.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ambika Devi, M., Das, N.P. Antiproliferative effect of polyunsaturated fatty acids and interleukin-2 on normal and abnormal human lymphocytes. Experientia 50, 489–492 (1994). https://doi.org/10.1007/BF01920754
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01920754